Developer and Partnership Differences in COVID-19 and Other Infections: Insights from DNA Vaccines.

J Mark Access Health Policy · 2024 · PMC11587068 · PMID 39588277

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

Thus, the rise of small biopharmaceutical companies, recently known as “emerging biopharma” [ 11 ], in the development of new vaccine platforms was a significant trend in COVID-19 vaccine development [ 12 , 13 ].

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.